Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -19.24% | 174.34% | 53.71% | -1.49% | 80.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.24% | 174.51% | 53.71% | -1.49% | 80.27% |
| Cost of Revenue | -11.85% | 295.54% | 19.15% | -6.60% | -6.54% |
| Gross Profit | -23.36% | 105.37% | 84.40% | 2.56% | 272.85% |
| SG&A Expenses | -10.12% | -27.32% | -2.00% | 20.19% | 26.69% |
| Depreciation & Amortization | 0.00% | 0.00% | 6.67% | 6.67% | 0.00% |
| Other Operating Expenses | 283.77% | 300.66% | -276.11% | 641.08% | -916.67% |
| Total Operating Expenses | 9.73% | 78.38% | -22.13% | 37.64% | 5.38% |
| Operating Income | -431.64% | -15.73% | 685.93% | -253.83% | 119.77% |
| Income Before Tax | -423.76% | -16.34% | 683.02% | -236.66% | 120.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -423.76% | -16.34% | 683.02% | -236.66% | 120.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -423.76% | -16.34% | 683.02% | -236.66% | 120.76% |
| EBIT | -431.64% | -15.73% | 685.93% | -253.83% | 119.77% |
| EBITDA | -420.07% | -15.83% | 698.02% | -257.67% | 120.44% |
| EPS Basic | -410.81% | 2.73% | 577.27% | -193.85% | 118.50% |
| Normalized Basic EPS | -413.04% | 2.63% | 412.70% | -197.50% | 118.40% |
| EPS Diluted | -410.81% | 2.73% | 577.27% | -193.85% | 118.50% |
| Normalized Diluted EPS | -413.04% | 2.63% | 412.70% | -197.50% | 118.40% |
| Average Basic Shares Outstanding | 5.25% | 19.39% | 21.99% | 14.20% | 10.63% |
| Average Diluted Shares Outstanding | 5.25% | 19.39% | 21.99% | 14.20% | 10.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |